论文部分内容阅读
目的观察应用头孢哌酮舒巴坦钠与痰热清联用与单用头孢哌酮舒巴坦钠治疗婴幼儿肺炎的临床疗效。方法随机将符合标准的病例分为治疗组42例和对照组40例,治疗组为头孢哌酮舒巴坦钠与痰热清联用组,对照组为单用头孢哌酮舒巴坦钠组,其他治疗方法相同。结果治疗组的临床疗效明显优于对照组,并能缩短病程(P<0.05),两组相比差异有统计学意义。结论头孢哌酮舒巴坦钠联用痰热清治疗婴幼儿肺炎比单用头孢哌酮舒巴坦钠疗效好,能大大缩短病程,且未发现明显不良反应,值得临床推广应用。
Objective To observe the clinical efficacy of cefoperazone-sulbactam combined with Tanreqing and cefoperazone-sulbactam sodium in the treatment of infantile pneumonia. Methods A total of 42 cases were randomly divided into treatment group (n = 42) and control group (n = 40). The treatment group was cefoperazone-sulbactam sodium combined with Tanreqing and the control group was cefoperazone sulbactam sodium alone Other treatments are the same. Results The clinical efficacy of the treatment group was significantly better than the control group, and can shorten the course of disease (P <0.05), the difference between the two groups was statistically significant. Conclusion Cefoperazone sulbactam combined with Tanreqing treatment of infantile pneumonia than cefoperazone sulbactam sodium curative effect, can greatly shorten the course of the disease, and no significant adverse reactions, it is worth promoting the clinical application.